{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:07:20Z","timestamp":1790647640443,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopaedics & Traumatology: Surgery & Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.otsr.2022.103219","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T03:42:27Z","timestamp":1643600547000},"page":"103219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients"],"prefix":"10.1016","volume":"108","author":[{"given":"Veronique A.J.I.M.","family":"van Rijckevorsel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert R.","family":"Roukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjallingius M.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otsr.2022.103219_bib0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.injury.2011.05.017","article-title":"Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis","volume":"43","author":"Hu","year":"2012","journal-title":"Injury"},{"key":"10.1016\/j.otsr.2022.103219_bib0195","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1302\/0301-620X.99B8.BJJ-2016-1119.R1","article-title":"Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur","volume":"99\u2013B","author":"de Jong","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2022.103219_bib0200","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ageing\/afu065","article-title":"Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis","volume":"43","author":"Smith","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.otsr.2022.103219_bib0205","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00402-019-03118-6","article-title":"Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials","volume":"139","author":"Xiao","year":"2019","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.otsr.2022.103219_bib0210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12891-019-2670-5","article-title":"Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study","volume":"20","author":"Xie","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.otsr.2022.103219_bib0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.39.4.503","article-title":"The hemodynamic response to chronic anemia","volume":"39","author":"Duke","year":"1969","journal-title":"Circulation"},{"key":"10.1016\/j.otsr.2022.103219_bib0220","doi-asserted-by":"crossref","first-page":"e9552","DOI":"10.1097\/MD.0000000000009552","article-title":"Efficacy and safety of tranexamic acid in total hip replacement: A PRISMA-compliant meta-analysis of 25 randomized controlled trials","volume":"96","author":"Zhu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.otsr.2022.103219_bib0225","first-page":"125","article-title":"Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry","volume":"67","author":"Sch\u00f6chl","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.otsr.2022.103219_bib0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/BOT.0000000000000837","article-title":"Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial","volume":"31","author":"Watts","year":"2017","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.otsr.2022.103219_bib0235","first-page":"30703082e1","article-title":"The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"issue":"10","key":"10.1016\/j.otsr.2022.103219_bib0240","first-page":"3065","article-title":"Tranexamic Acid Use in Total Joint Arthroplasty: The Clinical Practice Guidelines Endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons","volume":"33","author":"Fillingham","year":"2018","journal-title":"Hip Society, and Knee Society. J Arthroplasty"},{"issue":"1","key":"10.1016\/j.otsr.2022.103219_bib0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/0259-1162.128908","article-title":"Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty","volume":"8","author":"Emara","year":"2014","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.otsr.2022.103219_bib0250","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1302\/0301-620X.101B9.BJJ-2018-1096.R1","article-title":"Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty?. A randomized controlled trial","volume":"101\u2013B","author":"Bradley","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2022.103219_bib0255","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.injury.2015.06.039","article-title":"The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study","volume":"46","author":"Lee","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.otsr.2022.103219_bib0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"CRASH-2 trial collaborators, Shakur H","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.otsr.2022.103219_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.otsr.2022.103219_bib0270","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2106\/JBJS.17.01518","article-title":"Perioperative tranexamic acid treatment and risk of cardiovascular events or death after total hip arthroplasty: a population-based cohort study from national danish databases","volume":"100","author":"Dastrup","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.otsr.2022.103219_bib0275","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.injury.2021.08.001","article-title":"Blood loss and transfusion rate compared among different dosing regimens of tranexamic acid administration in patients undergoing hip hemiarthroplasty for femoral neck fracture: A randomized controlled trial","volume":"52","author":"Narkbunnam","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.otsr.2022.103219_bib0280","doi-asserted-by":"crossref","DOI":"10.1177\/2151459318803851","article-title":"Intra-articular tranexamic acid injection during the hip hemi-arthroplasty in elderly patients: a retrospective study","volume":"9","author":"Liu","year":"2018","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"10.1016\/j.otsr.2022.103219_bib0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrneurol.2010.36","article-title":"Ischemic stroke in the elderly: an overview of evidence","volume":"6","author":"Chen","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.otsr.2022.103219_bib0290","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.2106\/JBJS.18.00834","volume":"100","author":"Ayers","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.otsr.2022.103219_bib0295","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1302\/0301-620X.103B3.BJJ-2020-1288.R1","article-title":"Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial","volume":"103\u2013B","author":"Nikolaou","year":"2021","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2022.103219_bib0300","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1302\/0301-620X.103B3.BJJ-2020-1375.R2","article-title":"Is tranexamic acid use in patients with a hip fracture safe?","volume":"103\u2013B","author":"Viberg","year":"2021","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2022.103219_bib0305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/aen236","article-title":"Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery","volume":"101","author":"Maxwell","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.otsr.2022.103219_bib0310","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1213\/ANE.0000000000001992","article-title":"Determination of perioperative blood loss: accuracy or approximation?","volume":"125","author":"Lopez-Picado","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.otsr.2022.103219_bib0315","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease control and prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otsr.2022.103219_bib0320","first-page":"A9408","article-title":"Blood is not for everyone: the usefulness of erythrocyte transfusion","volume":"159","author":"Kranenburg","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.otsr.2022.103219_bib0325","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019","volume":"45","author":"Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.otsr.2022.103219_bib0330","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.otsr.2022.103219_bib0335","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00198-018-4786-0","article-title":"Preoperative antithrombotic therapy and risk of blood transfusion and mortality following hip fracture surgery: a Danish nationwide cohort study","volume":"30","author":"Daugaard","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.otsr.2022.103219_bib0340","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/bcp.13079","article-title":"A systematic review of tranexamic acid in hip fracture surgery","volume":"82","author":"Farrow","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.otsr.2022.103219_bib0345","volume":"28","author":"Haj-Younes","year":"2020","journal-title":"Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. J Orthop Surg (Hong Kong)"},{"key":"10.1016\/j.otsr.2022.103219_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2021.01.032","article-title":"The efficacy of intravenous tranexamic acid administration at induction in definitive hip fracture surgery: is there a role?","author":"Kanthasamy","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.otsr.2022.103219_bib0355","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.injury.2020.07.061","article-title":"Tranexamic acid in hip hemiarthroplasty","volume":"51","author":"Ashkenazi","year":"2020","journal-title":"Injury"},{"key":"10.1016\/j.otsr.2022.103219_bib0360","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010676","article-title":"Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients","volume":"6","author":"Gausden","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.otsr.2022.103219_bib0365","series-title":"Cyklokapron\u00ae - Product monograph [Internet]","first-page":"1","author":"Pfizer Canada","year":"2013"},{"key":"10.1016\/j.otsr.2022.103219_bib0370","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2106\/JBJS.21.00172","article-title":"Tranexamic acid was not associated with increased complications in high-risk patients with hip fracture undergoing arthroplasty","volume":"103","author":"Porter","year":"2021","journal-title":"J Bone Joint Surg Am"}],"container-title":["Orthopaedics & Traumatology: Surgery & Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187705682200024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187705682200024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T03:47:43Z","timestamp":1761796063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187705682200024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S187705682200024X"],"URL":"https:\/\/doi.org\/10.1016\/j.otsr.2022.103219","relation":{},"ISSN":["1877-0568"],"issn-type":[{"value":"1877-0568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients","name":"articletitle","label":"Article Title"},{"value":"Orthopaedics & Traumatology: Surgery & Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otsr.2022.103219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103219"}}